Works matching AU Richardson, Paul G.

Results: 215
    1
    2
    3
    4
    5

    New Treatments for Multiple Myeloma.

    Published in:
    Oncology (08909091), 2005, v. 19, n. 14, p. 1781
    By:
    • Richardson, Paul G.;
    • Schlossman, Robert;
    • Hideshima, Teru;
    • Anderson, Kenneth C.
    Publication type:
    Article
    6
    7
    8
    9

    Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.

    Published in:
    Expert Opinion on Therapeutic Targets, 2021, v. 25, n. 6, p. 423, doi. 10.1080/14728222.2021.1944101
    By:
    • Richardson, Edward;
    • García-Bernal, David;
    • Calabretta, Eleonora;
    • Jara, Rubén;
    • Palomo, Marta;
    • Baron, Rebecca M.;
    • Yanik, Gregory;
    • Fareed, Jawed;
    • Vlodavsky, Israel;
    • Iacobelli, Massimo;
    • Díaz-Ricart, Maribel;
    • Richardson, Paul G.;
    • Carlo-Stella, Carmelo;
    • Moraleda, Jose M.
    Publication type:
    Article
    10
    11
    12
    13

    Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.

    Published in:
    Nature Medicine, 2014, v. 20, n. 6, p. 599, doi. 10.1038/nm.3562
    By:
    • Cottini, Francesca;
    • Hideshima, Teru;
    • Xu, Chunxiao;
    • Sattler, Martin;
    • Dori, Martina;
    • Agnelli, Luca;
    • ten Hacken, Elisa;
    • Bertilaccio, Maria Teresa;
    • Antonini, Elena;
    • Neri, Antonino;
    • Ponzoni, Maurilio;
    • Marcatti, Magda;
    • Richardson, Paul G;
    • Carrasco, Ruben;
    • Kimmelman, Alec C;
    • Wong, Kwok-Kin;
    • Caligaris-Cappio, Federico;
    • Blandino, Giovanni;
    • Kuehl, W Michael;
    • Anderson, Kenneth C
    Publication type:
    Article
    14
    15

    One size does not fit all.

    Published in:
    Oncology (08909091), 2016, v. 30, n. 8, p. 747
    By:
    • Richardson, Paul G.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 6, p. 2227, doi. 10.1111/bjh.19386
    By:
    • Nooka, Ajay K.;
    • Kaufman, Jonathan L.;
    • Rodriguez, Cesar;
    • Jakubowiak, Andrzej;
    • Efebera, Yvonne;
    • Reeves, Brandi;
    • Wildes, Tanya M.;
    • Holstein, Sarah A.;
    • Anderson, Larry D.;
    • Badros, Ashraf;
    • Shune, Leyla;
    • Chari, Ajai;
    • Pei, Huiling;
    • Cortoos, Annelore;
    • Patel, Sharmila;
    • Lin, Thomas S.;
    • Voorhees, Peter M.;
    • Usmani, Saad Z.;
    • Richardson, Paul G.
    Publication type:
    Article
    24
    25

    Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 3, p. 639, doi. 10.1111/bjh.17887
    By:
    • Larocca, Alessandra;
    • Leleu, Xavier;
    • Touzeau, Cyrille;
    • Bladé, Joan;
    • Paner, Agne;
    • Mateos, María‐Victoria;
    • Cavo, Michele;
    • Maisel, Christopher;
    • Alegre, Adrían;
    • Oriol, Albert;
    • Raptis, Anastasios;
    • Rodriguez‐Otero, Paula;
    • Mazumder, Amitabha;
    • Laubach, Jacob;
    • Nadeem, Omar;
    • Sandberg, Anna;
    • Orre, Marie;
    • Torrång, Anna;
    • Bakker, Nicolaas A.;
    • Richardson, Paul G.
    Publication type:
    Article
    26
    27
    28

    Molecular dynamics of targeting CD38 in multiple myeloma.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 581, doi. 10.1111/bjh.17329
    By:
    • Malavasi, Fabio;
    • Faini, Angelo C.;
    • Morandi, Fabio;
    • Castella, Barbara;
    • Incarnato, Danny;
    • Oliviero, Salvatore;
    • Horenstein, Alberto L.;
    • Massaia, Massimo;
    • Donk, Niels W. C. J.;
    • Richardson, Paul G.
    Publication type:
    Article
    29
    30
    31
    32

    Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

    Published in:
    Cardiovascular Drugs & Therapy, 2022, v. 36, n. 3, p. 547, doi. 10.1007/s10557-021-07207-w
    By:
    • Castro, Pedro;
    • Palomo, Marta;
    • Moreno-Castaño, Ana Belen;
    • Fernández, Sara;
    • Torramadé-Moix, Sergi;
    • Pascual, Georgina;
    • Martinez-Sanchez, Julia;
    • Richardson, Edward;
    • Téllez, Adrián;
    • Nicolas, Josep M.;
    • Carreras, Enric;
    • Richardson, Paul G.;
    • Badimon, Juan José;
    • Escolar, Gines;
    • Diaz-Ricart, Maribel
    Publication type:
    Article
    33

    Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.

    Published in:
    EJHaem, 2023, v. 4, n. 4, p. 995, doi. 10.1002/jha2.759
    By:
    • Richardson, Paul G.;
    • Facon, Thierry;
    • Venner, Christopher P.;
    • Bahlis, Nizar J.;
    • Offner, Fritz;
    • White, Darrell;
    • Karlin, Lionel;
    • Benboubker, Lotfi;
    • Voog, Eric;
    • Yoon, Sung‐Soo;
    • Suzuki, Kenshi;
    • Shibayama, Hirohiko;
    • Zhang, Xiaoquan;
    • Villarreal, Miguel;
    • Twumasi‐Ankrah, Philip;
    • Labotka, Richard;
    • Rifkin, Robert M.;
    • Lonial, Sagar;
    • Kumar, Shaji K.;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    34

    Selinexor: Targeting a novel pathway in multiple myeloma.

    Published in:
    EJHaem, 2023, v. 4, n. 3, p. 792, doi. 10.1002/jha2.709
    By:
    • Mo, Clifton C.;
    • Yee, Andrew J.;
    • Midha, Shonali;
    • Hartley‐Brown, Monique A.;
    • Nadeem, Omar;
    • O'Donnell, Elizabeth K.;
    • Bianchi, Giada;
    • Sperling, Adam S.;
    • Laubach, Jacob P.;
    • Richardson, Paul G.
    Publication type:
    Article
    35
    36
    37

    Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma.

    Published in:
    EJHaem, 2021, v. 2, n. 1, p. 48, doi. 10.1002/jha2.120
    By:
    • Richardson, Paul G.;
    • Jagannath, Sundar;
    • Chari, Ajai;
    • Vogl, Dan T.;
    • Dimopoulos, Meletios A.;
    • Moreau, Philippe;
    • Dingli, David;
    • Wei, Lee‐Jen;
    • Richter, Joshua;
    • Biran, Noa;
    • Siegel, David;
    • Reichmann, William;
    • Li, Lingling;
    • Tang, Shijie;
    • Saint‐Martin, Jean‐Richard;
    • Joshi, Anita;
    • Kauffman, Michael;
    • Shah, Jatin;
    • Shacham, Sharon;
    • Lonial, Sagar
    Publication type:
    Article
    38

    Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib.

    Published in:
    EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.4
    By:
    • Richardson, Paul G.;
    • Nagler, Arnon;
    • Ben-Yehuda, Dina;
    • Badros, Ashraf;
    • Hari, Parameswaran N.;
    • Hajek, Roman;
    • Spicka, Ivan;
    • Kaya, Hakan;
    • LeBlanc, Richard;
    • Sung-Soo Yoon;
    • Kihyun Kim;
    • Martinez-Lopez, Joaquin;
    • Moshe Mittelman;
    • Shpilberg, Ofer;
    • Blake, Paul;
    • Teru Hideshima;
    • Colson, Kathleen;
    • Laubach, Jacob P.;
    • Ghobrial, Irene M.;
    • Leiba, Merav
    Publication type:
    Article
    39

    Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 687, doi. 10.1016/j.clml.2023.05.004
    By:
    • Sonneveld, Pieter;
    • Richardson, Paul G.;
    • Ludwig, Heinz;
    • Dimopoulos, Meletios-Athanasios;
    • Schjesvold, Fredrik H.;
    • Hajek, Roman;
    • Abdulhaq, Haifaa;
    • Thuresson, Marcus;
    • Norin, Stefan;
    • Bakker, Nicolaas A.;
    • Mateos, Maria-Victoria
    Publication type:
    Article
    40
    41

    P-224: Pomalidomide, bortezomib, and dexamethasone after 1 prior line of therapy in relapsed or refractory multiple myeloma (RRMM): A safety subanalysis of the phase 3 OPTIMISMM trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S163, doi. 10.1016/S2152-2650(21)02351-X
    By:
    • Weisel, Katja;
    • Dimopoulos, Meletios-Athanasios;
    • Oriol, Albert;
    • Beksac, Meral;
    • Dimopoulos, Fredrik;
    • Liberati, Anna Marina;
    • Lindsay, Jindriska;
    • White, Darrell;
    • San-Miguel, Jesús F.;
    • Moreau, Philippe;
    • Anderson Jr., Larry D.;
    • Lorocca, Alessandra;
    • Robak, Pawef;
    • Vogel, Prisca;
    • Jiang, Ruiyun;
    • Grote, Lara;
    • Peluso, Teresa;
    • Richardson, Paul G.
    Publication type:
    Article
    42

    P-212: DREAMM-5 platform trial: Belantamab mafodotin (belamaf; GSK2857916) in combination with five different novel agents in patients with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S156, doi. 10.1016/S2152-2650(21)02339-9
    By:
    • Richardson, Paul G.;
    • Trudel, Suzanne;
    • Callander, Natalie S.;
    • Nooka, Ajay;
    • Song, Kevin;
    • Uttervall, Katarina;
    • Minnema, Monique C.;
    • Rodríguez-Otero, Paula;
    • Struemper, Herbert;
    • Yeakey, Anne;
    • de Oca, Rocio Montes;
    • Smith, L. Mary;
    • Jackson, Nicola;
    • Kaisermann, Morrys;
    • Im, Ellie;
    • Basile, Frank G.;
    • Ahlers, Christoph M.;
    • Holkova, Beata;
    • Gupta, Ira;
    • Kremer, Brandon E.
    Publication type:
    Article
    43

    P-203: EXCALIBER: a phase 3 study comparing iberdomide, daratumumab, and dexamethasone (IberDd) with daratumumab, bortezomib, and dexamethasone (DVd) in patients with relapsed or refractory multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S150, doi. 10.1016/S2152-2650(21)02330-2
    By:
    • Lonial, Sagar;
    • Berdeja, Jesus G.;
    • Dimopoulos, Meletios-Athanasios;
    • Jagannath, Sundar;
    • Knop, Stefan;
    • Hang Quach;
    • Rodríguez-Otero, Paula;
    • Richardson, Paul G.;
    • Sorrell, April;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • Tuong Vi Nguyen;
    • Hong, Kevin;
    • Peluso, Teresa;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    44

    P-193: Elotuzumab plus pomalidomide/dexamethasone for relapsed/refractory multiple myeloma: final overall survival from the phase 2 ELOQUENT-3 trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S143, doi. 10.1016/S2152-2650(21)02320-X
    By:
    • Dimopoulos, Meletios-Athanasios;
    • Dytfeld, Dominik;
    • Grosicki, Sebastian;
    • Moreau, Philippe;
    • Takezako, Naoki;
    • Hori, Mitsuo;
    • Leleu, Xavier;
    • LeBlanc, Richard;
    • Suzuki, Kenshi;
    • Raab, Marc;
    • Richardson, Paul G.;
    • McKiver, Mihaela Popa;
    • Ying-Ming Jou;
    • David Yao;
    • Das, Prianka;
    • San-Miguel, Jesús F.
    Publication type:
    Article
    45

    P-150: Quality of life, psychological distress, and prognostic awareness in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S117, doi. 10.1016/S2152-2650(21)02277-1
    By:
    • O'Donnell, Elizabeth;
    • Shapiro, Yael;
    • Nadeem, Omar;
    • Yee, Andrew J.;
    • Laubach, Jacob;
    • Branagan, Andrew;
    • Anderson, Kenneth;
    • Mo, Clifton;
    • Munshi, Nikhil C.;
    • Ghobrial, Irene;
    • Sperling, Adam;
    • Agyemang, Emerentia;
    • Burke, Jill;
    • Harrington, Cynthia;
    • Richardson, Paul G.;
    • Raje, Noopur;
    • El-Jawahri, Areej
    Publication type:
    Article
    46

    P-134: Quality of life, psychological distress, and prognostic awareness in caregivers of patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S108, doi. 10.1016/S2152-2650(21)02261-8
    By:
    • ODonnell, Elizabeth;
    • Shapiro, Yael;
    • Nadeem, Omar;
    • Yee, Andrew J.;
    • Laubach, Jacob;
    • Branagan, Andrew;
    • Anderson, Kenneth;
    • Mo, Clifton;
    • Munshi, Nikhil C.;
    • Ghobrial, Irene;
    • Sperling, Adam;
    • Agyemang, Emerentia;
    • Burke, Jill;
    • Harrington, Cynthia;
    • Richardson, Paul G.;
    • Raje, Noopur;
    • El-Jawahri, Areej
    Publication type:
    Article
    47
    48

    OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S29, doi. 10.1016/S2152-2650(21)02119-4
    By:
    • Branagan, Andrew;
    • Lei, Matthew;
    • Yee, Andrew J.;
    • O'Donnell, Elizabeth;
    • Castillo, Jorge J.;
    • Raje, Noopur;
    • Treon, Steven P.;
    • Flynn, Catherine;
    • Burke, Jill;
    • Harrington, Cynthia;
    • Agyemang, Emerentia;
    • Mo, Clifton;
    • Nadeem, Omar;
    • Richardson, Paul G.;
    • Maebius, Allison;
    • Onyewadume, Chukwuamaka;
    • Panaroni, Cristina;
    • Meid, Kirsten;
    • Bernstein, Zachary;
    • Lyons, Rebecca
    Publication type:
    Article
    49

    OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
    By:
    • Lonial, Sagar;
    • Richardson, Paul G.;
    • Popat, Rakesh;
    • Stadtmauer, Edward A.;
    • Larsen, Jeremy T.;
    • Oriol, A.;
    • Knop, Stefan;
    • Jagannath, Sundar;
    • Cook, Gordon;
    • Badros, Ashraf Z.;
    • Rodríguez-Otero, Paula;
    • Siegel, David S.;
    • Tuong Vi Nguyen;
    • Micco, Antonia Di;
    • Amin, Alpesh;
    • Min Chen;
    • Kueenburg, Elisabeth;
    • van de Donk, Niels W.C.J.
    Publication type:
    Article
    50

    OAB-033: Loss-of-function of GABARAP drives tumor resistance to bortezomib-induced immunogenic cell death in multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S21, doi. 10.1016/S2152-2650(21)02107-8
    By:
    • Gulla, Annamaria;
    • Morelli, Eugenio;
    • Samur, Mehmet K;
    • Botta, Cirino;
    • Johnstone, Megan;
    • Bianchi, Giada;
    • Fulciniti, Mariateresa;
    • Leona Yamamoto;
    • Prabhala, Rao;
    • Wen, Kenneth;
    • Richardson, Paul G.;
    • Yu-Tzu Tai;
    • Chauhan, Dharminder;
    • Teru Hideshima;
    • Munshi, Nikhil C.;
    • Anderson, Kenneth
    Publication type:
    Article